RWEOne Awarded 'Best RWE Solution 2026' at Global Pharma Tech Awards

Judges specifically highlighted the platform's AI-driven validation engine and event-driven audit trail architecture as differentiators that deliver measurable sponsor outcomes.

FOR IMMEDIATE RELEASE

London — June 30, 2026 — RWEOne was last night named the winner of the 'Best Real-World Evidence Solution 2026' award at the Global Pharma Tech Awards, hosted in London. The award recognizes the RWEOne platform's measurable impact on clinical study timelines, data quality, and audit readiness across 500+ delivered studies.

Why the Judges Selected RWEOne

• AI validation engine v3 delivering 45% Phase 4 timeline reductions for a top-20 pharma sponsor
• RabbitMQ-based immutable audit trail fabric with zero findings in 2026 Part 11 revalidation
• CDISC CDASH 2026 certification for the eCRF builder, announced earlier the same month
• 412 new pre-qualified investigator sites activated across the APAC expansion

CEO Comments

Awards are nice, but the real honor is seeing the outcomes our sponsor customers report: faster studies, cleaner data, zero audit findings, and medicines getting to patients sooner. This award belongs to every member of the RWEOne team and every investigator in our global network.

Media Contact:
RWEOne Press Office
[email protected]